STAQ Pharma recalls
STAQ Pharma has 6 recalls on record with the FDA and USDA, the earliest in 2022 and the latest reported on 22 Oct 2025. 3 are still ongoing. 3 were reported in the last 12 months.
Total recalls6since 2022
Last 12 months3reported
Class I233% of total
Ongoing3latest 22 Oct 2025
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 2 33%Class II 1 17%Class III 3 50%
Why staq pharma is recalled
Product types
By year
Ongoing staq pharma recalls
3 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS III | FentaNYL Citrate PF, 500mcg/ (10mcg/mL) in Nacl recalled by STAQ Pharma | STAQ Pharma | Other | Nationwide |
| Drug | CLASS III | Hydromorphone HCL PF, 10mg/ 2mg/mL) in Nacl, Injection recalled | STAQ Pharma | Other | Nationwide |
| Drug | CLASS III | Ketamine Hydrochloride, 50mg/ (10mg/mL), Injection recalled | STAQ Pharma | Other | Nationwide |
All staq pharma recalls, newest first
6 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS III | FentaNYL Citrate PF, 500mcg/ (10mcg/mL) in Nacl recalled by STAQ Pharma | STAQ Pharma | Other | Nationwide |
| Drug | CLASS III | Hydromorphone HCL PF, 10mg/ 2mg/mL) in Nacl, Injection recalled | STAQ Pharma | Other | Nationwide |
| Drug | CLASS III | Ketamine Hydrochloride, 50mg/ (10mg/mL), Injection recalled | STAQ Pharma | Other | Nationwide |
| Drug | CLASS II | ROPivacaine HCl 2% PF in Sodium Chloride 1,000 mg recalled | STAQ Pharma | Packaging Defects | Nationwide |
| Drug | CLASS I | Morphine Sulfate PF 25 mg/ (1 mg/mL) in NaCl in Single Dose Syringe recalled | STAQ Pharma | Labeling Errors | CO, OH, TX |
| Drug | CLASS I | HYDROmorphone HCl PF 10 mg/ 2mg/mL) in NaCl in Single Dose Syringe recalled | STAQ Pharma | Labeling Errors | CO, OH, TX |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.